Sheba Medical Center
Sheba Medical Center
Israel, Ramat Gan
Einat Shacham Shmueli
26 years of experience
Clinic is certified :
| Israel | Turkey | Austria | |
| Esophagectomy | from $14,032 | from $23,400 | from $30,000 |
| Chemotherapy for breast cancer | from $22,500 | from $1,200 | from $15,000 |
| Resection of the esophagus | - | from $21,600 | - |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Radiation therapy for esophageal carcinoma | - | from $7,000 | from $20,000 |
Dr. Pelles Sharon is a highly respected oncologist with notable contributions to clinical research, including studies on patient attitudes towards clinical trials.
Professor Ofer Merimsky heads the Unit for Soft Tissue and Bone Oncology at Sourasky Medical Center, with decades of expertise in complex cancer cases.
Prof. Arber wrote over 300 scientific papers on gastrointestinal cancer – he leads the Cancer Prevention Center at Ichilov.
Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.
She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.
Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.
Primary treatment for esophageal cancer in Israel centers on multimodal protocols integrating robotic esophagectomy, targeted chemotherapy, and precision radiation. JCI-accredited facilities like Sourasky and Assuta utilize multidisciplinary teams to combine systemic therapies with advanced surgical resection for localized and advanced malignancies.
Bookimed Expert Insight: Israeli oncology centers like Sourasky (Ichilov) demonstrate high specialization by appointing dedicated heads for gastrointestinal tumor centers rather than generalists. This focus supports success rates reached by high-volume surgeons like Dr. Joseph Klauzner, who manages complex reconstructions after over 40 years of surgical experience.
Patient Consensus: Patients note that neoadjuvant chemotherapy followed by surgery is the standard pathway for locally advanced cases. Many emphasize that recovery takes 3–6 months and requires early involvement from nutritionists to manage dietary changes.
Israel reports high success rates for esophageal cancer, specifically achieving 90% survival for surgical esophagectomy in specialized centers. Early-stage intervention yields survival rates exceeding 85%, while advanced squamous cell carcinoma outcomes have improved through newly approved immunotherapy protocols like tislelizumab at JCI-accredited facilities.
Bookimed Expert Insight: While success rates are high, clinical volume is the true differentiator in Israel. Sourasky Medical Center alone treats over 1,800,000 patients annually with a 90% oncology success rate. Choosing a high-volume specialist like Professor Nadir Arber or Dr. Joseph Klauzner, who has 45+ years of practice, ensures your treatment plan is backed by significant surgical experience and research-driven protocols.
Patient Consensus: Patients note that early detection via routine endoscopy can jump survival to 80%. Many emphasize preparing for post-treatment challenges like nutrition and swallowing by seeking speech therapy referrals early.
Israeli surgeons perform esophagectomy using minimally invasive and robotic-assisted techniques at JCI-accredited centers like Sourasky Medical Center and Assuta. These protocols typically involve laparoscopic or thoracoscopic approaches, including Ivor Lewis and McKeown procedures, to remove cancerous tissue while prioritizing rapid recovery and 90% oncology success rates.
Bookimed Expert Insight: While many seek private care at Assuta for speed, Sourasky Medical Center houses specialized units like the Integrated Cancer Prevention Center. Data shows these high-volume academic hubs manage over 1,800,000 annual patient visits. This volume is critical because specialists like Dr. Nadir Arber and Dr. Auala Hubert bring over 30 years of expertise to complex gastrointestinal resections.
Patient Consensus: Patients note that choosing high-volume centers with enhanced recovery protocols can significantly shorten hospital stays. They emphasize preparing for lifelong diet adjustments, as the stomach pull-up reconstruction often requires managing reflux or specialized feeding early on.
Doctors in Israel use chemotherapy or radiation before surgery, known as neoadjuvant therapy, to shrink esophageal tumors and eliminate microscopic cancer cells. This approach improves surgical success rates, preserves surrounding healthy tissue, and reduces the risk of cancer returning after the main procedure.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report a 90% average success rate for oncology treatments. Their strategy often involves using advanced PET/CT imaging specifically after neoadjuvant therapy. This ensures surgeons only proceed when scans confirm the tumor has reached an operable size.
Patient Consensus: Patients note that while pre-surgical therapy can cause temporary swallowing difficulties, it often improves long-term quality of life. Many emphasize the importance of nutritional support during this phase to manage weight loss effectively.
Recovery after esophageal cancer surgery in Israel includes 5 to 14 days of hospitalization, beginning with intensive care monitoring. Vital healing takes 6 to 8 weeks, while full adaptation to dietary changes often requires up to 1 year of specialist follow-up.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report a 90% success rate by utilizing multidisciplinary teams. Data shows that recovery is most successful when surgeons with 30+ years of experience, such as Dr. Joseph Klauzner or Dr. Auala Hubert, lead the procedure. Their expertise in managing complex gastrointestinal connections significantly reduces the risk of leaks during the critical first 3 weeks.
Patient Consensus: Many patients find the period without oral food psychologically difficult and recommend preparing liquid recipes early. Long-term fatigue and significant weight loss are common, making 24/7 home support essential during the first 2 months.
Recognized Israeli hospitals for esophageal cancer include Sourasky Medical Center, Hadassah Medical Center, and Sheba Medical Center. These facilities utilize robotic esophagectomy, NGS genetic testing, and advanced radiotherapy. Accredited by JCI and Newsweek, these centers integrate multidisciplinary oncology teams to deliver personalized surgical and systemic protocols.
Bookimed Expert Insight: While many patients focus only on surgery, data shows a major quality differentiator is the availability of integrated research centers. Facilities like Sourasky and Hadassah manage nearly 2,000,000 patient visits annually. This massive volume allows their specialists, such as Prof. Joseph Klauzner with over 45 years of practice, to maintain expertise in complex Whipple and esophageal reconstructions that smaller centers rarely perform.
Patient Consensus: Patients note that Israeli hospitals provide faster access to experimental combinations like immunotherapy and chemo than many Western facilities. Many highlight the benefit of international patient desks which help coordinate virtual consultations and navigate visa logistics efficiently.